- Title
- Exome sequencing efficacy and phenotypic expansions involving esophageal atresia/tracheoesophageal fistula plus
- Creator
- Sy, Mary R.; Chauhan, Jaynee; Islam, Lily; Goel, Himanshu; Bain, Nicole; Park, Soo-Mi; Mohammed, Shehla; Dieterich, Klaus; Coutton, Charles; Satre, Veronique; Vieville, Gaelle; Donaldson, Alan; Prescott, Katrina; Beneteau, C; Ghoumid, J; Van den Bogaert, K; Boogaerts, A; Boudry, E; Vanlerberghe, C; Petit, F; Bernardini, L; Torres, B; Mattina, T; Imam, Aliza; Carli, D; Mandrile, G; Pinelli, M; Brunetti-Pierri, N; Neas, K; Beddow, R; Torring, PM; Faletra, F; Spedicati, B; Gasparini, P; Kraus, Alison; Mussa, A; Ferrero, GB; Lampe, A; Lam, W; Bi, W; Bacino, CA; Kuwahara, A; Bush, JO; Zhao, X; Luna, PN; Beleza, Ana; Shaw, CA; Rosenfeld, JA; Scott, DA; Salkeld, Lee; Hosdurga, Saraswati; Parker, Michael; Vasudevan, Pradeep
- Relation
- American Journal of Medical Genetics. Part A Vol. 188, Issue 12, p. 3492-3504
- Publisher Link
- http://dx.doi.org/10.1002/ajmg.a.62976
- Publisher
- Wiley-Blackwell
- Resource Type
- journal article
- Date
- 2022
- Description
- Esophageal atresia/tracheoesophageal fistula (EA/TEF) is a life-threatening birth defect that often occurs with other major birth defects (EA/TEF+). Despite advances in genetic testing, a molecular diagnosis can only be made in a minority of EA/TEF+ cases. Here, we analyzed clinical exome sequencing data and data from the DECIPHER database to determine the efficacy of exome sequencing in cases of EA/TEF+ and to identify phenotypic expansions involving EA/TEF. Among 67 individuals with EA/TEF+ referred for clinical exome sequencing, a definitive or probable diagnosis was made in 11 cases for an efficacy rate of 16% (11/67). This efficacy rate is significantly lower than that reported for other major birth defects, suggesting that polygenic, multifactorial, epigenetic, and/or environmental factors may play a particularly important role in EA/TEF pathogenesis. Our cohort included individuals with pathogenic or likely pathogenic variants that affect TCF4 and its downstream target NRXN1, and FANCA, FANCB, and FANCC, which are associated with Fanconi anemia. These cases, previously published case reports, and comparisons to other EA/TEF genes made using a machine learning algorithm, provide evidence in support of a potential pathogenic role for these genes in the development of EA/TEF.
- Subject
- esophageal atresia; exome sequencing; fanconi anemia; NRXN1; TCF4; tracheoesophageal fistula
- Identifier
- http://hdl.handle.net/1959.13/1488327
- Identifier
- uon:52411
- Identifier
- ISSN:1552-4825
- Language
- eng
- Reviewed
- Hits: 14366
- Visitors: 14283
- Downloads: 0
| Thumbnail | File | Description | Size | Format |
|---|